Laurion Capital Management LP Evelo Biosciences, Inc. Transaction History

Laurion Capital Management LP

  • $8.4 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$3.81 - $5.73 $86,106 - $129,498
-22,600 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$3.53 - $6.12 $79,778 - $138,312
22,600 New
22,600 $111,000
Q3 2018

Nov 13, 2018
SELL
$11.93 - $14.76 $1.79 Million - $2.21 Million
-150,000 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$11.39 - $16.26 $1.71 Million - $2.44 Million
150,000 New
150,000 $1.77 Million

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email